Alpha Centric Advisors LLC Harmony Biosciences Holdings, Inc. Transaction History
Alpha Centric Advisors LLC
- $118 Million
- Q3 2024
A detailed history of Alpha Centric Advisors LLC transactions in Harmony Biosciences Holdings, Inc. stock. As of the latest transaction made, Alpha Centric Advisors LLC holds 97,000 shares of HRMY stock, worth $3.15 Million. This represents 3.28% of its overall portfolio holdings.
Number of Shares
97,000
Previous 122,000
20.49%
Holding current value
$3.15 Million
Previous $3.68 Million
5.3%
% of portfolio
3.28%
Previous 3.04%
Shares
4 transactions
Others Institutions Holding HRMY
# of Institutions
242Shares Held
45.2MCall Options Held
108KPut Options Held
49.2K-
Valor Management LLC Chicago, IL11.2MShares$364 Million100.0% of portfolio
-
Black Rock Inc. New York, NY5.84MShares$190 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.47MShares$113 Million0.0% of portfolio
-
Vivo Capital, LLC Palo Alto, CA2.61MShares$84.7 Million15.24% of portfolio
-
Pacer Advisors, Inc. Malvern, PA1.93MShares$62.6 Million0.18% of portfolio
About Harmony Biosciences Holdings, Inc.
- Ticker HRMY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,161,400
- Market Cap $1.92B
- Description
- Harmony Biosciences Holdings, Inc., a commercial-stage pharmaceutical company, develops and commercializes therapies for patients with rare neurological disorders in the United States. Its product, WAKIX is a medication for the treatment of excessive daytime sleepiness in adult patients with narcolepsy. The company was formerly known as Harmony ...